The patent situation concerning the treatment of diseases associated with autoantibodies directed against G-protein-coupled receptors
{{output}}
Agonist-like autoantibodies against receptors of the G-protein-coupled signal cascade have been identified as the pathogenic principle for a variety of diseases, especially those of the heart and vascular system. Consequently, the elimination or neutralization... ...
